Sector consensus Hangzhou Tigermed Consulting Co., Ltd
Equities
300347
CNE100001KV8
Biotechnology & Medical Research
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 55.11 CNY | -1.25% |
|
-2.92% | -2.80% |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
 | CN¥67.77 | +21.43% | 14 | ||||||
| CHF 675.78 | +39.48% | 23 | ||||||
| $409.68 | +43.6% | 25 | ||||||
| ₩253,958.33 | +23.28% | 24 | ||||||
| $236.19 | +44.96% | 21 | ||||||
| $129.35 | +36.06% | 20 | ||||||
| $247.03 | +24.73% | 16 | ||||||
| $489.69 | +10.33% | 13 | ||||||
| €71.71 | +16.29% | 14 | ||||||
| $93.9 | +29.8% | 22 | ||||||
| $77.93 | +57.34% | 14 | ||||||
| €108.72 | +5.76% | 6 | ||||||
| $55.23 | +34.32% | 15 | ||||||
| $75.25 | +46.2% | 12 | ||||||
| $197.47 | +29.35% | 15 | ||||||
| $600.71 | +98.01% | 17 | ||||||
| $138.64 | +42.27% | 14 | ||||||
| $111.07 | -2.82% | 14 | ||||||
| CN¥37.92 | +33.65% | 12 | ||||||
| Average | 13,567.49 | +33.37% | 16 | ||||||
| Weighted average by Cap. | 27,621.23 | +34.49% | 19 |
Select your edition
All financial news and data tailored to specific country editions
